65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79722D0164
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 651B Solicitation number
Last date to order 84% complete
IDV ceiling
$225,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Argenx US, Inc. (UEI: YQQMVL36XZ11) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on August 1, 2022, with an ultimate completion date of July 31, 2027. The contract, with a ceiling value of $225,000, represents a life cycle change to incorporate a permanent Federal Contractor Partnership (FCP) for the supply of drugs, pharmaceuticals, and hematology-related products. The contract carries no set-aside designation and is funded through the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs responsible for delivering healthcare services to veterans across its designated geographic region.

Under this Federal Supply Schedule vehicle, Argenx US, Inc. will supply pharmaceutical and hematology products to support the Department of Veterans Affairs' medical procurement needs within VISN 12's service territory. The permanent FCP incorporation indicates a long-term partnership framework designed to streamline procurement processes and ensure consistent availability of specialized pharmaceutical products for the veteran population served by this network. The multiple-award structure allows for competition among eligible contractors while maintaining the stability and continuity necessary for critical pharmaceutical supply chains supporting VA healthcare delivery.

IDV awards

IDV Agency Ceiling Awarded
36E79726A0027 BPA for vyvgart hytrulo National Acquisition Center (VA) $703,256,709

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00014 · Life cycle change to incorporate permanent FCP $0
Supplemental Agreement for work within scope P00013 · PL2026 pricing updates $0
Supplemental Agreement for work within scope P00011 · Commercial items (changes) temp $0
Supplemental Agreement for work within scope P00010 · Addition of one 42-2A product to contract. $0
Other Administrative Action P00009 · Administrative change to add a new point of contact (POC) $0
Supplemental Agreement for work within scope P00008 · Provisional FCP $0
Supplemental Agreement for work within scope P00007 · Public law 2025 update $0
Supplemental Agreement for work within scope P00006 · Lifecycle change to permanent FCP $0
Supplemental Agreement for work within scope P00005 · Public law 2024 update $0
Supplemental Agreement for work within scope P00004 · Lifecycle change $0
Supplemental Agreement for work within scope P00003 · Product addition $0
Supplemental Agreement for work within scope P00002 · Administrative change $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36F79722D0164?

36F79722D0164 was awarded to Argenx US, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 1, 2022.

How much is contract 36F79722D0164 worth?

36F79722D0164's own ceiling is $225,000.

Who can order from contract 36F79722D0164?

36F79722D0164 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79722D0164 part of a contract vehicle?

Yes. 36F79722D0164 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79722D0164 competed?

The extent of competition for 36F79722D0164 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV